Plegridy (peginterferon beta-1a)
- Region
- 🇪🇺 EU
- Active substance
- peginterferon beta-1a
- Company
- Biogen Netherlands B.V.
- Status
- Authorised
- Therapeutic area
- Multiple Sclerosis
- CHMP opinion
- Wed 21 May 2014
- EU approval
- Fri 18 Jul 2014
- Application
- EMEA/H/C/002827
- ATC
- L03AB13
- Official record
- www.ema.europa.eu
Indication
Treatment of relapsing remitting multiple sclerosis in adult patients.
Regulatory milestones
No milestones recorded in the last year.
Follow Plegridy
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.